Business Description
Utah Medical Products Inc
NAICS : 339112
SIC : 3841
ISIN : US9174881089
Share Class Description:
UTMD: Ordinary SharesDescription
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 314.81 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 23.86 | |||||
| Beneish M-Score | -3.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.3 | |||||
| 3-Year EBITDA Growth Rate | 3.8 | |||||
| 3-Year EPS without NRI Growth Rate | 10 | |||||
| 3-Year FCF Growth Rate | 4.3 | |||||
| 3-Year Book Growth Rate | 7.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51 | |||||
| 9-Day RSI | 46.94 | |||||
| 14-Day RSI | 45.54 | |||||
| 6-1 Month Momentum % | -16.65 | |||||
| 12-1 Month Momentum % | -27.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 22.56 | |||||
| Quick Ratio | 20.53 | |||||
| Cash Ratio | 19.72 | |||||
| Days Inventory | 174.18 | |||||
| Days Sales Outstanding | 28.98 | |||||
| Days Payable | 17.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.73 | |||||
| Dividend Payout Ratio | 0.26 | |||||
| 3-Year Dividend Growth Rate | 1.7 | |||||
| Forward Dividend Yield % | 1.75 | |||||
| 5-Year Yield-on-Cost % | 1.81 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 1.75 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.81 | |||||
| Operating Margin % | 33.4 | |||||
| Net Margin % | 33.12 | |||||
| FCF Margin % | 43.09 | |||||
| ROE % | 13.72 | |||||
| ROA % | 12.82 | |||||
| ROIC % | 34.46 | |||||
| ROC (Joel Greenblatt) % | 87.17 | |||||
| ROCE % | 13.47 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.01 | |||||
| PE Ratio without NRI | 15.01 | |||||
| Shiller PE Ratio | 15.96 | |||||
| Price-to-Owner-Earnings | 14.43 | |||||
| PEG Ratio | 4.84 | |||||
| PS Ratio | 4.97 | |||||
| PB Ratio | 1.94 | |||||
| Price-to-Tangible-Book | 2.27 | |||||
| Price-to-Free-Cash-Flow | 11.53 | |||||
| Price-to-Operating-Cash-Flow | 11.19 | |||||
| EV-to-EBIT | 9.15 | |||||
| EV-to-EBITDA | 6.63 | |||||
| EV-to-Revenue | 3.06 | |||||
| EV-to-FCF | 7.1 | |||||
| Price-to-Projected-FCF | 0.97 | |||||
| Price-to-DCF (Earnings Based) | 1.3 | |||||
| Price-to-DCF (FCF Based) | 1 | |||||
| Price-to-Median-PS-Value | 0.75 | |||||
| Price-to-Graham-Number | 1.34 | |||||
| Price-to-Net-Current-Asset-Value | 2.51 | |||||
| Price-to-Net-Cash | 2.91 | |||||
| Earnings Yield (Greenblatt) % | 10.93 | |||||
| FCF Yield % | 8.79 | |||||
| Forward Rate of Return (Yacktman) % | 10.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:UTMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Utah Medical Products Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 50.224 | ||
| EPS (TTM) ($) | 4.57 | ||
| Beta | 0.19 | ||
| Volatility % | 18.7 | ||
| 14-Day RSI | 45.54 | ||
| 14-Day ATR ($) | 1.402773 | ||
| 20-Day SMA ($) | 69.1775 | ||
| 12-1 Month Momentum % | -27.48 | ||
| 52-Week Range ($) | 66.9 - 100.59 | ||
| Shares Outstanding (Mil) | 3.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Utah Medical Products Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Utah Medical Products Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Utah Medical Products Inc Frequently Asked Questions
What is Utah Medical Products Inc(UTMD)'s stock price today?
The current price of UTMD is $68.58. The 52 week high of UTMD is $100.59 and 52 week low is $66.90.
When is next earnings date of Utah Medical Products Inc(UTMD)?
The next earnings date of Utah Medical Products Inc(UTMD) is 2024-04-25 Est..
Does Utah Medical Products Inc(UTMD) pay dividends? If so, how much?
The Dividend Yield %  of Utah Medical Products Inc(UTMD) is 1.73% (As of Today), Highest Dividend Payout Ratio of Utah Medical Products Inc(UTMD) was 0.47. The lowest was 0.21. And the median was 0.32. The  Forward Dividend Yield % of Utah Medical Products Inc(UTMD) is 1.75%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers